Tixagevimab Antibody
Tixagevimab is a humanized monoclonal antibody that neutralizes SARS-CoV-2 by binding to the spike protein's receptor-binding domain, preventing viral entry. It is utilized in research applications for both in vitro neutralization assays and in vivo preclinical studies of COVID-19 therapeutics and prophylaxis.
Product Specifications
Product Name Alternative
AZD8895, AZD 8895
Target
SARS-CoV
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Infectious Disease & Virology
Concentration
10.61 mg/mL
Purity
95.00% (May vary between batches)
Molecular Weight
146.48 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6298865-01 0.1 mL
FEZF1, NT (FEZF1, FEZ, ZNF312B, Fez family zinc finger protein 1, Zinc finger protein 312B) (MaxLight 650)
Sign In for Pricing
View Details MBS6298865-02 5x 0.1 mL
FEZF1, NT (FEZF1, FEZ, ZNF312B, Fez family zinc finger protein 1, Zinc finger protein 312B) (MaxLight 650)
Sign In for Pricing
View Details ARP36894_P050-FITC 100 µL
HSF1 Antibody - C-terminal region : FITC (ARP36894_P050-FITC)
Sign In for Pricing
View Details